Bioactivity:LX-4211 is an orally bioavailable inhibitor of the sodium-glucose co-transporter subtype 1 (SGLT1) and 2 (SGLT2), with potential antihyperglycemic activity.
CAS Nr:
1018899-04-1
Purity:
98%
SMILES:
[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)SC)O)O)O)c1cc(c(cc1)Cl)Cc1ccc(cc1)OCC
Formula:
C21H25ClO5S
Molecular weight:
424,93
Pathway:
GPCR/G Protein
Target:
SGLT